Beijing Zhongneng Xingye Investment Consulting has launched an attack on Kangmei Pharmaceutical in an action that looks a lot like the kind of short-selling tactic adopted by Muddy Waters. Kangmei shares have dropped over the allegations of fraud in land purchases, even though the company has denied wrongdoing.

Related Summaries